Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules.

J. Gonzalez, P. Stern, S. Dutta, C. Sismero

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	247–260
Journal	International Journal of Research in Marketing
Volume	25
Issue number	4
DOIs	https://doi.org/10.1016/j.ijresmar.2008.08.002
Publication status	Published - 1 Dec 2008

Access to Document

@article{dba040b9a6914844bdd4104c31c57e6d,

title = "Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules.",

author = "J. Gonzalez and P. Stern and S. Dutta and C. Sismero",

year = "2008",

month = dec,

day = "1",

doi = "10.1016/j.ijresmar.2008.08.002",

language = "English",

volume = "25",

pages = "247–260",

journal = "International Journal of Research in Marketing",

issn = "0167-8116",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules.

AU - Gonzalez, J.

AU - Stern, P.

AU - Dutta, S.

AU - Sismero, C.

PY - 2008/12/1

Y1 - 2008/12/1

U2 - 10.1016/j.ijresmar.2008.08.002

DO - 10.1016/j.ijresmar.2008.08.002

M3 - Article

SN - 0167-8116

VL - 25

SP - 247

EP - 260

JO - International Journal of Research in Marketing

JF - International Journal of Research in Marketing

IS - 4

ER -